Groupe Bruxelles Lambert SA (FRA:EAI)

Inozyme Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,846	8,388	9,465	10,631	14,689	12,640
Market Cap Growth	-0.26%	-11.38%	-10.97%	-27.62%	16.21%	-13.81%
Enterprise Value	15,064	15,722	16,798	17,186	19,531	19,245
Last Close Price	73.05	61.63	65.85	67.87	86.79	71.93
PE Ratio	-	63.40	5.49	-	52.69	32.33
PS Ratio	1.37	1.25	1.40	1.96	2.11	1.92
PB Ratio	0.62	0.52	0.56	0.63	0.67	0.62
P/TBV Ratio	1.68	1.17	1.10	1.89	1.08	0.90
P/FCF Ratio	12.94	9.97	17.03	39.48	23.05	13.74
P/OCF Ratio	7.34	6.31	8.44	12.98	14.11	10.28
EV/Sales Ratio	2.33	2.35	2.49	3.17	2.81	2.92
EV/EBITDA Ratio	12.67	13.01	11.28	24.71	14.07	13.61
EV/EBIT Ratio	24.01	19.46	17.50	83.71	19.96	18.45
EV/FCF Ratio	22.04	18.69	30.22	63.82	30.65	20.92
Debt / Equity Ratio	0.54	0.50	0.49	0.62	0.35	0.29
Debt / EBITDA Ratio	7.09	6.02	5.13	12.21	5.04	3.86
Debt / FCF Ratio	11.19	9.59	15.03	38.51	12.01	6.54
Asset Turnover	0.24	0.24	0.22	0.16	0.22	0.21
Inventory Turnover	1.83	1.80	1.85	1.80	1.77	2.15
Quick Ratio	1.38	1.51	1.26	0.92	1.52	1.22
Current Ratio	1.91	1.95	1.81	1.55	1.96	1.80
Return on Equity (ROE)	-1.41%	0.38%	2.29%	-0.73%	1.74%	2.05%
Return on Assets (ROA)	1.21%	1.80%	1.94%	0.38%	1.89%	2.11%
Return on Capital (ROIC)	1.39%	2.04%	2.28%	0.45%	2.19%	2.39%
Return on Capital Employed (ROCE)	2.30%	3.30%	3.70%	0.70%	3.10%	3.70%
Earnings Yield	-1.16%	1.58%	18.21%	-5.50%	1.90%	3.09%
FCF Yield	7.73%	10.03%	5.87%	2.53%	4.34%	7.28%
Dividend Yield	4.57%	8.11%	4.18%	4.05%	3.17%	3.48%
Payout Ratio	-	268.33%	22.06%	-	136.44%	125.04%
Buyback Yield / Dilution	6.70%	4.65%	4.25%	0.78%	1.46%	1.84%
Total Shareholder Return	11.27%	12.76%	8.42%	4.83%	4.63%	5.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.